IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Imunon, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 11, 2026
$0.98−0.04 (-3.43%)
Close on Oct 19, 2026
- Market cap
- $4.95M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.1050 (−80.65%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2026
Valuation
- Market cap
- $4.95M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.47
- Dividend yield
- –
- Free cash flow yield
- -286.22%
Fundamentals
- Net income
- -$14.64M
- EPS, diluted
- -$5.59
- Free cash flow
- -$14.18M
- Book value per share
- $0.67
- Diluted shares
- 5M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$14.81M
Net income
-$14.64M
EPS, diluted
-$5.59
Free cash flow
–
Reported periodTrailing twelve months